✉news BusinessFinance first seen 7 d ago, last 7 d ago, peak #9
Arcutis Biotherapeutics files quarterly report
Original: ARQT 10-Q & SEC Filings
Arcutis Biotherapeutics (NASDAQ: ARQT) has filed its Form 10-Q with the US Securities and Exchange Commission, making its latest quarterly financial disclosures available to investors. The filing covers the company's financial condition and operating results, and finance watchers are monitoring the disclosures for details on revenue, expenses and cash position.
Why now: The newly filed quarterly report gives investors fresh financial data on the dermatology company.
Arcutis BiotherapeuticsARQTSecurities and Exchange Commission
Rank over time, top of the chart is #1. 3 snapshots from 7 d ago to 7 d ago.
Evidence
- ARQT 10-Q & SEC Filings · Yahoo Finance
API: https://socialmediatrends-api.osmike.com/v1/trends/4958542